1. Bedtime dosing of olmesartan-amlodipine improves nocturnal BP control.
2. The study enrolled 720 adults across 15 hospitals in China.
3. Significant reductions in nighttime SBP were noted in the bedtime group.
4. No increase in adverse events or nocturnal hypotension.
5. Subgroup benefits observed in men and older adults.
6. Potential implications for cardiovascular risk reduction.
7. Calls for longer-term trials in diverse populations.

Source: JAMA Network Open